Daniel Dolan

Insider Reports History

Entity
Individual
Location
C/O Nabriva Therapeutics Plc, 1000 Continental Drive, Suite 600, King Of Prussia, PA
Signature
/s/ J. Christopher Naftzger, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Dolan:

Insider Reports Filed by Daniel Dolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBRVF Nabriva Therapeutics plc Aug 11, 2022 4 $0 4 Aug 15, 2022 Chief Financial Officer
NBRVF Nabriva Therapeutics plc Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Financial Officer